Tumor-infiltrating B lymphocytes promote melanoma progression and resistance to therapy
In a multi-institutional collaborative study, scientists at The Wistar Institute and the Medical University of Vienna, Austria, have identified the role of tumor-infiltrating or tumor-associated B-cells ("TABs") in melanoma ...
Sep 19, 2017
0
0